NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/06/2026
Voltar para busca
Dado oficial do USPTO
PA INSIGHTS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PA INSIGHTS
ST13
US500000098593158Classe
35, 42
Pedido
98593158
Registro
8286460
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
21
Atualização mais recente
02/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
10/06/2024
Data de registro
02/06/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/06/2026
Última transação
02/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
07/06/2024
Primeiro uso no comércio
07/06/2024
Código do desenho
4
Tipo de titular
16
Localização do titular
Chesterfield, MO, US
Examinador
ELTON, DAVID JONATHAN
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
D2 Pharma Consulting LLC
Representantes
Kevin C. Staed Carmody MacDonald P.C.
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business management consultingstrategic planning and business advisory services provided to medical and pharmaceutical industries; Business management of logistics for others; Business management of reimbursement programs for others; Business services provided to a network of health care providersthe negotiation and execution of contracts with health care payors; Consulting services in the field of patient relationship management for healthcare providers; Cost management for the health care benefit plans of others; Cost price analysis; Logistics management in the field of healthcare; Negotiation of business contracts for others; New product commercialization services; Pharmaceutical cost management services and drug utilization review services; Business assistanceadvisory and consulting services in the field of product distributionproductionoperationslogisticssupply chains; Business assistanceadvisory and consulting services in the field of medical product approval; Professional credentialing verification services in the field of healthcareverifying the skills and knowledge of licensed professionals on behalf of others; Providing business intelligence services in the fields of medical devicespharmaceuticals and the life sciences; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval
Classe 42
Software as a service (SAAS) services featuring software for reviewing pharmacy accreditation and re-accreditation; Software as a service (SAAS) services featuring software for monitoring compliance with pharmacy regulationsrequirementsaudits; Software as a service (SAAS) services featuring software for prior authorization initiationprocessingsupport and analysis; Software as a service (SAAS) services featuring software for prior authorization analysisnamely approval ratingresponse timedifficulty estimationworkflow predictionsappeal likelihoodappeal outcome estimationdenial predictions and rationale; Software as a service (SAAS) services featuring software for providing information and actionable intelligence for prior authorizations and providing guidance as to complexitydifficulty in completinglikelihood for denial during the prior authorization process; Software as a service (SAAS) services featuring software for facilitating the onboarding of patients to new medicationsproviding ongoing patient education and facilitation of patient compliance to therapy; Software as a service (SAAS) services featuring software using artificial intelligence for prior authorization analysisnamely approval ratingresponse timedifficulty estimationworkflow predictionsappeal likelihoodappeal outcome estimationdenial predictions and rationale
Publicações
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
13/05/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
13/05/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
14/04/2026
IUAF
USE AMENDMENT FILED
07/11/2025
EISU
TEAS STATEMENT OF USE RECEIVED
07/11/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30/09/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2025
PUBO
PUBLISHED FOR OPPOSITION
03/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/04/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/01/2025
GNRT
NON-FINAL ACTION E-MAILED
08/01/2025
CNRT
NON-FINAL ACTION WRITTEN
08/01/2025
DOCK
ASSIGNED TO EXAMINER
17/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/12/2024
NWAP
NEW APPLICATION ENTERED
10/06/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PA INSIGHTS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.